CA Patent

CA2618513A1 — Unsaturated heterocyclic derivatives

Assigned to Ariad Pharmaceuticals Inc · Expires 2007-02-22 · 19y expired

What this patent protects

This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.

USPTO Abstract

This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CA2618513A1
Jurisdiction: CA
Classification: —
Expires: 2007-02-22
Drug substance claim: No
Drug product claim: No
Assignee: Ariad Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.